ADPT Stock Analysis: Buy, Sell, or Hold?
ADPT - Adaptive Biotechnologies Corporation Common Stock
$21.02
-0.04 (-0.19%)
▼
5d:
-2.23%
30d:
+23.14%
90d:
+64.35%
BUY
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 04, 2026
21d
Get Alerted When ADPT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ADPT shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: ADPT shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: ADPT is currently trading at $21.02, which is considered slightly high relative to its 30-day fair value range of $17.28 to $21.12.
Technical Outlook: Technically, ADPT is in a strong uptrend. Immediate support is located at $19.77, while resistance sits at $22.80.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ADPT is in a strong uptrend. Immediate support is located at $19.77, while resistance sits at $22.80.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$17.28 -
$21.12
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.6%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($20.57)
Trading Range Analysis
30-Day Trading Range
$17.28 -
$21.12
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$19.77
Resistance Level
$22.80
Current Trend
Strong Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-83.27
Wall Street Target
$20.57
(-2.3%)
Revenue Growth (YoY)
35.1%
Profit Margin
-16.8%
Share & Embed Analysis
Last updated: July 13, 2026 4:21 PM ET
Data refreshes hourly during market hours. Next update: 5:21 PM
Data refreshes hourly during market hours. Next update: 5:21 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADPT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Julie Rubinstein
SELL
19060 shares
2026-04-24
Julie Rubinstein
SELL
19060 shares
2026-04-22
Julie Rubinstein
SELL
30941 shares
2026-04-21
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$591 | 64 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 67 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$157 | 60 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$271 | 54 HOLD |
Advanced ADPT Option Strategies
Professional options setups generated by AI based on today's ADPT price and gamma walls.
